Deciphering Preserved Autonomic Function After Multiple Sclerosis

NARecruitingINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 17, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

January 31, 2026

Conditions
Multiple SclerosisControl SubjectsAutonomic Dysreflexia
Interventions
DIAGNOSTIC_TEST

Tests of sympathetic inhibition

Bolus phenylephrine infusion using the Oxford technique will generate the need to inhibit sympathetic activity. Similarly, resting state Mayer waves will be assessed with regard to heart rate and blood pressure responses.

DIAGNOSTIC_TEST

Tests of sympathetic activation

Cold pressor test of the hand will be used to cause sympathetic activation. Valsalva's maneuver will assess the ability to buffer against blood pressure fall (phase II).

DIAGNOSTIC_TEST

Testing of autonomic dysreflexia

Cold pressor test of the foot and bladder pressor response will be tested.

Trial Locations (1)

55902

RECRUITING

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT07012135 - Deciphering Preserved Autonomic Function After Multiple Sclerosis | Biotech Hunter | Biotech Hunter